Free Trial
NYSEARCA:REVS

Columbia Research Enhanced Value ETF (REVS) Price, Holdings, & News

$26.79 +0.15 (+0.56%)
As of 11:56 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Columbia Research Enhanced Value ETF (NYSEARCA:REVS)

Key Stats

Today's Range
$26.73
$26.83
50-Day Range
$25.24
$27.13
52-Week Range
$21.79
$27.24
Volume
566 shs
Average Volume
13,196 shs
Market Capitalization
$79.03 million
Assets Under Management
$75.19 million
Dividend Yield
1.72%
Net Expense Ratio
0.19%
Aggregate Rating
Moderate Buy

ETF Overview

Columbia Research Enhanced Value ETF Expenses

TypeREVSLarge Cap ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.19%0.58%0.56%0.51%0.53%
Other Expenses0.00%0.27%0.56%0.59%0.56%
Total Expense0.19%0.65%0.76%0.74%0.73%
Fee Waiver0.00%-0.23%-0.66%-0.71%-0.63%
Net Expense0.19%0.62%0.63%0.58%0.60%
Receive REVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Columbia Research Enhanced Value ETF and its competitors with MarketBeat's FREE daily newsletter.

REVS ETF News Headlines

HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
Columbia Research Enhanced Real Estate ETF
REVS Columbia Research Enhanced Value ETF
See More Headlines

REVS ETF - Frequently Asked Questions

Columbia Research Enhanced Value ETF's stock was trading at $24.73 at the beginning of the year. Since then, REVS shares have increased by 7.7% and is now trading at $26.64.

Columbia Research Enhanced Value ETF's top institutional shareholders include Wealth Enhancement Advisory Services LLC (3.07%) and Frederick Financial Consultants LLC (1.17%).

Shares of REVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Columbia Research Enhanced Value ETF investors own include Geo Group (GEO), Global X SuperDividend REIT ETF (SRET), BlackRock Capital Investment (BKCC), British American Tobacco (BTI), Energy Transfer (ET), International Business Machines (IBM) and Annaly Capital Management (NLY).

Fund Details

Issuer
Columbia
Fund Name
Columbia Research Enhanced Value ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:REVS
Inception Date
9/25/2019
Fund Manager
Christopher Lo, Jason Wang
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
The Beta Advantage Research Enhanced U.S. Value Index
Category
Size and Style
Focus
Large Cap
Development Level
Developed Markets
Region
North America
Number of Holdings
314

Fund Statistics

Assets Under Management
$75.19 million
Average Daily Volume
$0.00
Discount/Premium
0.02%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Columbia Management Investment Advisers, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
ALPS Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
N/A
Short Interest
5,800 shs

Miscellaneous

Beta
0.89
Creation Unit
50,000
Creation Fee
$500.00
10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Top 10 REVS Holdings

REVS Sector Exposure

REVS Industry Exposure


This page (NYSEARCA:REVS) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners